Patent Assignment
Reel/Frame 030816/0442
Assignment of Assignor's Interest
Recorded: 2013-07-17
Pages: 3
Assignor
DRUZGALA, PASCAL J.
Executed: 2013-05-20
Assignee
ARMETHEON, INC.
325 SHARON PARK DRIVE, # 303, MENLO PARK, CALIFORNIA, 94025
Covered Property
(1)
Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 016464 Frame 0278. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics. the Assignee Name Should Not Have Had Inc..
Aug 31, 2012
From: IRWIN, IAN; PALME, MONICA; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028890/0001 →
Assignment of Assignor's Interest
Oct 4, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029080/0290 →
Release of Security Interest
Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Assignment of Assignor's Interest
Dec 9, 2016
From: ARMETHEON, INC.
To: NARONAPRIDE, LLC
Reel/Frame 040699/0559 →
Change of Name
Dec 9, 2016
From: NARONAPRIDE, LLC
To: RENEXXION, LLC
Reel/Frame 040876/0342 →